These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2152918)

  • 1. Calcium binding to extracellular sites of skeletal muscle calcium channels regulates dihydropyridine binding.
    Ebata H; Mills JS; Nemcek K; Johnson JD
    J Biol Chem; 1990 Jan; 265(1):177-82. PubMed ID: 2152918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of divalent cation chelation on dihydropyridine binding in isolated cardiac sarcolemma vesicles.
    Schilling WP
    Biochim Biophys Acta; 1988 Aug; 943(2):220-30. PubMed ID: 2969752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium ions inhibit the allosteric interaction between the dihydropyridine and phenylalkylamine binding site on the voltage-gated calcium channel in heart sarcolemma but not in skeletal muscle transverse tubules.
    Murphy BJ; Tuana BS
    Can J Physiol Pharmacol; 1990 Nov; 68(11):1389-95. PubMed ID: 1962734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding Ca2+ to intracellular or to extracellular sites of dihydropyridine receptor of rabbit skeletal muscle discriminates between in vitro binding of Ca2+-channel agonist and antagonist.
    Kanngiesser U; Pongs O
    Eur J Biochem; 1989 May; 181(2):467-73. PubMed ID: 2540975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of binding of dihydropyridine calcium channel ligands to skeletal muscle membranes: evidence for low-affinity sites and for the involvement of G proteins.
    Dunn SM; Bladen C
    Biochemistry; 1991 Jun; 30(23):5716-21. PubMed ID: 1645998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced calcium sensitivity of dihydropyridine binding to calcium channels in spontaneously hypertensive rats.
    Ebata H; Natsume T; Mitsuhashi T; Yaginuma T
    Hypertension; 1991 Feb; 17(2):234-41. PubMed ID: 1846842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydropyridine binding to the L-type Ca2+ channel in rabbit heart sarcolemma and skeletal muscle transverse-tubules: role of disulfide, sulfhydryl and phosphate groups.
    Murphy BJ; Washkurak AW; Tuana BS
    Biochim Biophys Acta; 1990 May; 1052(2):333-9. PubMed ID: 2159349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voltage-dependent calcium channels in skeletal muscle transverse tubules. Measurements of calcium efflux in membrane vesicles.
    Dunn SM
    J Biol Chem; 1989 Jul; 264(19):11053-60. PubMed ID: 2472387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular approach to the calcium channel.
    Glossmann H; Ferry DR; Goll A; Linn T
    Adv Myocardiol; 1985; 5():41-76. PubMed ID: 2578683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification, characterization, and photoaffinity labeling of the dihydropyridine receptor associated with the L-type calcium channel from bovine adrenal medulla.
    Murphy BJ; Rogers CA; Sunahara RK; Lemaire S; Tuana BS
    Mol Pharmacol; 1990 Feb; 37(2):173-81. PubMed ID: 2154669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive heterotropic allosteric regulators of dihydropyridine binding increase the Ca2+ affinity of the L-type Ca2+ channel. Stereoselective reversal by the novel Ca2+ antagonist BM 20.1140.
    Staudinger R; Knaus HG; Glossmann H
    J Biol Chem; 1991 Jun; 266(17):10787-95. PubMed ID: 1645709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of the dihydropyridine calcium channel blocker (+)-[3H] isopropyl-4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-5-methoxycarbonyl-2, 6-dimethyl-3-pyridinecarboxylate (PN200-110) to RINm5F membranes and cells: characterization and functional significance.
    Yaney GC; Stafford GA; Henstenberg JD; Sharp GW; Weiland GA
    J Pharmacol Exp Ther; 1991 Aug; 258(2):652-62. PubMed ID: 1713965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [3H]HOE166 defines a novel calcium antagonist drug receptor--distinct from the 1,4 dihydropyridine binding domain.
    Grassegger A; Striessnig J; Weiler M; Knaus HG; Glossmann H
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Dec; 340(6 Pt 2):752-9. PubMed ID: 2561307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of inorganic calcium channel blockers on dihydropyridine binding to cardiac sarcolemma.
    Schilling WP; Zaher MC; Rampe D
    Mol Pharmacol; 1990 Jan; 37(1):80-9. PubMed ID: 2137194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydropyridine receptors in transverse tubules from normal and dystrophic chicken skeletal muscle.
    Moro G; Saborido A; Delgado J; Molano F; Megias A
    J Muscle Res Cell Motil; 1995 Oct; 16(5):529-42. PubMed ID: 8567940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-affinity binding sites for 1,4-dihydropyridines in skeletal muscle transverse tubule membranes revealed by changes in the fluorescence of felodipine.
    Dunn SM; Bladen C
    Biochemistry; 1992 Apr; 31(16):4039-45. PubMed ID: 1533154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solubilization and partial purification of putative calcium channels labelled with [3H]-nimodipine.
    Glossmann H; Ferry DR
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Aug; 323(4):279-91. PubMed ID: 6314149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Mg++ on the effect of diltiazem to increase dihydropyridine binding to receptors on Ca++-channels in chick cardiac and skeletal muscle membranes.
    Maan AC; Ptasienski J; Hosey MM
    J Pharmacol Exp Ther; 1986 Dec; 239(3):768-74. PubMed ID: 2432217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [3H]PN200-110 and [3H]ryanodine binding and reconstitution of ion channel activity with skeletal muscle membranes.
    Hamilton SL; Alvarez RM; Fill M; Hawkes MJ; Brush KL; Schilling WP; Stefani E
    Anal Biochem; 1989 Nov; 183(1):31-41. PubMed ID: 2559627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin binds with high affinity to voltage-dependent L-type Ca2+ channels. Evidence for an agonistic action.
    Knaus HG; Scheffauer F; Romanin C; Schindler HG; Glossmann H
    J Biol Chem; 1990 Jul; 265(19):11156-66. PubMed ID: 2162834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.